Following the new Saudi Food and Drug Authority (SFDA) guidance on Review and Approval of AI and Big Data-Based Medical Devices, our expert lawyers from our Healthcare & Life Sciences sector group, along with our Digital & Data practice, Nick O'Connell and Christina Sochacki, Esq., discuss the basis on which Big Data and AI-based software will be considered a medical device and other highlights from the new guidance.
Listen to the full episode now: https://bit.ly/34GKVhT